The literature has reported that PAPP-A is increased in breast [27], lung [47], and ovarian cancers [48], whereas it has been found to be decreased in renal cell carcinoma tissues and may act as a tumor suppressor [49]. Here, PAPPA is linked to renal cell carcinoma.